Status:
COMPLETED
Vitiligo Skin Transplantation
Lead Sponsor:
Henry Ford Health System
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body whi...
Eligibility Criteria
Inclusion
- Be at least 18 years old
- Have a diagnosis of vitiligo with no news lesions or growth of old lesions in the past 6 months
- Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form
- Agree to follow and undergo all study-related procedures
Exclusion
- Female patients who are breastfeeding, pregnant, or planning to become pregnant
- Patients with a history of developing vitiligo or keloids at sites of trauma
- Patients self-reported as having HIV or Hepatitis C
- Patients self-reported as having uncontrolled Diabetes Mellitus
- The investigator feels the patient should not participate in the study for any reason
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00830713
Start Date
January 1 2009
End Date
October 1 2011
Last Update
September 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Medical Center, New Center One
Detroit, Michigan, United States, 48202